The invention is based on the isolation of antibodies that were made to a polypeptide having the amino acid sequence for a truncated VEGF-D. One of these antibodies can interfere with the activity of VEGF-D mediated by VEGFR-2 and interfere with the binding of VEGF-D to VEGFR-3 but does not interfere...http://www.google.fr/patents/US6730489?utm_source=gb-gplus-shareBrevet US6730489 - Antibodies to truncated VEGF-D and uses thereof
